Happel David
- SEC CIK
- 0001623567
In the past year, 2 open-market sale filings worth $561.9K and no purchases.
Current role at each company
- SGMT Sagimet Biosciences Inc.President & CEOas of Jul 22, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $561.9K
- 2 filings
- Net
- −$561.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Happel David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 22, 2026 (view filing)4:05 PM ET | Jul 20 | 2 days | Happel DavidPresident & CEO | SSaleSeries A Common Stock | −64.1K | $7.76 | −$497.1K | −8.0%741.6K after | |
| Feb 12, 2026 (view filing) | Feb 10 | 2 days | Happel DavidPresident & CEO | SSaleSeries A Common Stock | −12.1K | $5.36 | −$64.9K | −1.8%677.6K after | |
| Jul 23, 2025 (view filing) | Jul 21 | 2 days | Happel DavidPresident & CEO | SSaleSeries A Common Stock | −65.5K | $9.13 | −$597.8K | −8.7%689.7K after | |
| Mar 28, 2024 (view filing) | Mar 26 | 2 days | Happel DavidPresident & CEO | PPurchaseSeries A Common Stock | +12.1K | $5.27 | +$63.8K | +1.9%639.2K after | |
| Dec 8, 2023 (view filing) | Dec 7 | 1 day | Happel DavidPresident & CEO | PPurchaseSeries A Common Stock | +1.60K | $4.10 | +$6.56K | +0.3%627.1K after | |
| Nov 20, 2023 (view filing) | Nov 16 | 4 days | Happel DavidPresident & CEO | PPurchaseSeries A Common Stock | +590 | $2.35 | +$1.39K | New position590 after |